Please login to the form below

Not currently logged in
Email:
Password:

Immodulon Therapeutics bolsters senior team

Dr Jerome Zeldis and Dr Graham Burton join as executive vice chairman and COO

GrahamIndependent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman.

Prior to his new role, Dr Zeldis served as chief medical officer for Celgene and he also held the role of chief executive officer for Celgene Global Health, gaining expertise in clinical research, medical affairs and drug safety.

He said: “I am particularly pleased to be joining Immodulon, which I see as one of the most exciting biopharmaceutical players in the industry.”

Also joining from Celgene is Dr Graham Burton (pictured right), who previously served the pharma group as its senior vice president of regulatory, pharmacovigilance and clinical quality and has over 30 years’ experience in the pharmaceutical industry. At Immodulon he takes up the roles of chief operating officer.

Hugo Mackenzie Smith, board director, Immodulon Therapeutics, said: “I have no doubt that Jerry and Graham’s wealth of experience and impressive track record at Celgene will support the progression of the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.

4th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics